Clearstead Advisors’s PaxMedica, Inc. Common Stock PXMD Stock Holding History

Clearstead Advisors’s Portfolio PXMD Stock Details PXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1	Closed	-$1	–	2085
2024 Q1	$1	Sell	1 -2,243	-100%	-$1.32K	﹤0.01%	1542
2023 Q4	$1.7K	Sell	2,244 -2,245	-50%	-$5.2K	﹤0.01%	1310
2023 Q3	$21.8K	Buy	+4,489	New	+$43.5K	﹤0.01%	1008

Other funds holding PXMD

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Clearstead Advisors's PXMD Position: Q2 2024 in Review

Clearstead Advisors sold out of PaxMedica, Inc. Common Stock (PXMD) in Q2 2024, closing a stake of 1 share — an estimated $1 sold.

Clearstead Advisors first reported a position in PXMD in Q3 2023 and held it in 3 quarters. The position peaked at $21.8K in Q3 2023. 1 fund tracked by Wall St. Rank holds PXMD as of Q2 2024.

Clearstead Advisors reported no remaining PaxMedica, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Clearstead Advisors sold 1 PaxMedica, Inc. Common Stock share in Q2 2024, an estimated $1.
Clearstead Advisors first reported a position in PaxMedica, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Clearstead Advisors's PaxMedica, Inc. Common Stock position peaked at $21.8K in Q3 2023.
1 fund tracked by Wall St. Rank held PaxMedica, Inc. Common Stock as of Q2 2024.

Based on Clearstead Advisors's 13F filing for Q2 2024, filed 12 Aug 2024.